U.S. drug development consultancy Certara Inc said on Thursday it sold shares in its initial public offering at $23 apiece, above its target range, to raise about $670 million. The IPO valued Certara, which is owned by Stockholm-based private equity firm EQT, at $3.5...
JPMorgan Chase & Co.’s Highbridge Capital Management is in talks to raise $1 billion or more for a strategy dedicated to investing in special purpose acquisition companies and related financial instruments, according to people with knowledge of the matter. The New...
The attention is focused on the country’s office market, where low-cost call centers have made way for research laboratories that offer more stable clients and surer rents Some of the world’s biggest investors are snapping up office space in India with plans to turn...
Private equity firm Monarch Alternative Capital LP, advised by Willkie, said Tuesday that it has closed its latest fund after securing about $3 billion from limited partners, with plans to target distressed opportunities brought about by the effects of the coronavirus...
Crossplane Capital, a Dallas-based private equity firm that targets control investments in niche manufacturing, value-added distribution and industrial business services companies, today announced the final closing of its inaugural fund, Crossplane Capital Fund, at... 